Prime Medicine, Inc. (PRME) income statement
PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.55−0.29 (-7.55%)
Close on Nov 20, 2026Market cap $643.89MP/E –Yield –
Prime Medicine, Inc. financial ratios
See a number that looks wrong?